Udho Thadani to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Udho Thadani has written about Dose-Response Relationship, Drug.
Connection Strength
0.362
-
Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Am J Med Sci. 2011 Jan; 341(1):1-9.
Score: 0.082
-
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris. Am J Cardiol. 1997 Apr 15; 79(8):1025-30.
Score: 0.032
-
Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group. Am J Cardiol. 1994 Jul 01; 74(1):9-17.
Score: 0.026
-
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation. 1991 Dec; 84(6):2398-408.
Score: 0.022
-
Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group. Am Heart J. 1989 Nov; 118(5 Pt 2):1135.
Score: 0.019
-
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates. Clin Pharmacokinet. 1988 Jul; 15(1):32-43.
Score: 0.017
-
Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study. J Cardiovasc Pharmacol. 1988; 12 Suppl 7:S114.
Score: 0.017
-
Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986 Oct; 105(4):485-92.
Score: 0.015
-
Assessment of "optimal" beta blockade in treating patients with angina pectoris. Acta Med Scand Suppl. 1985; 694:178-87.
Score: 0.013
-
Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982 Feb 01; 49(2):411-9.
Score: 0.011
-
Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction. Clin Pharmacokinet. 2002; 41(6):445-52.
Score: 0.011
-
Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation. 1980 Sep; 62(3):491-502.
Score: 0.010
-
Propranolol in angina pectoris: comparison of therapy given two and four times daily. Am J Cardiol. 1980 Jul; 46(1):117-23.
Score: 0.010
-
Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectoris. Circulation. 1980 Feb; 61(2):266-76.
Score: 0.010
-
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med. 1979 Apr 05; 300(14):750-5.
Score: 0.009
-
Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy. Circulation. 1979 Mar; 59(3):571-9.
Score: 0.009
-
Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation. 1998 Nov 17; 98(20):2117-25.
Score: 0.009
-
Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy. Eur J Pharmacol. 1998 Oct 23; 359(2-3):191-200.
Score: 0.009
-
Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators. Am J Cardiol. 1997 May 15; 79(10):1401-5.
Score: 0.008
-
Comparative anti-hypertensive effectiveness of beta-adrenoreceptor antagonists with different pharmacological properties: dose-response studies during acute and chronic administration. Clin Sci Mol Med Suppl. 1976 Dec; 3:541s-544s.
Score: 0.008
-
Conversion from immediate-release to extended-release diltiazem in angina pectoris. Clin Cardiol. 1994 Sep; 17(9):484-8.
Score: 0.007
-
Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: dose-response studies. Clin Pharmacol Ther. 1988 Mar; 43(3):308-16.
Score: 0.004
-
Atenolol for ventricular ectopy: a dose-response study. Clin Pharmacol Ther. 1987 Jan; 41(1):118-23.
Score: 0.004
-
Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment. Br Med J. 1976 Jul 03; 2(6026):7-9.
Score: 0.002